300519 Stock Overview
Zhejiang Xinguang Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Xinguang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.80 |
| 52 Week High | CN¥17.90 |
| 52 Week Low | CN¥8.45 |
| Beta | 0.24 |
| 1 Month Change | -0.72% |
| 3 Month Change | 26.26% |
| 1 Year Change | -15.29% |
| 3 Year Change | -33.01% |
| 5 Year Change | 2.60% |
| Change since IPO | 57.09% |
Recent News & Updates
Recent updates
Earnings Not Telling The Story For Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519) After Shares Rise 38%
Oct 18
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40
May 26Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)
Apr 16Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement
Feb 26Shareholder Returns
| 300519 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.3% | -1.9% | -1.2% |
| 1Y | -15.3% | -1.8% | 11.8% |
Return vs Industry: 300519 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 300519 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300519 volatility | |
|---|---|
| 300519 Average Weekly Movement | 11.8% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300519's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300519's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 315 | Yue Jun Wang | www.xgpharma.com |
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food. It offers pharmaceutical products for vascular and trauma diseases, including respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
Zhejiang Xinguang Pharmaceutical Co., Ltd. Fundamentals Summary
| 300519 fundamental statistics | |
|---|---|
| Market cap | CN¥2.21b |
| Earnings (TTM) | CN¥43.44m |
| Revenue (TTM) | CN¥270.50m |
50.8x
P/E Ratio8.2x
P/S RatioIs 300519 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300519 income statement (TTM) | |
|---|---|
| Revenue | CN¥270.50m |
| Cost of Revenue | CN¥181.78m |
| Gross Profit | CN¥88.71m |
| Other Expenses | CN¥45.27m |
| Earnings | CN¥43.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 32.80% |
| Net Profit Margin | 16.06% |
| Debt/Equity Ratio | 0% |
How did 300519 perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield147%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:39 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Xinguang Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|